−3.225 AUD
−36.57 M AUD
94.95 K AUD
10.84 M
About ZELIRA THERAPEUTICS LIMITED
Sector
CEO
Oludare Odumosu
Headquarters
Perth
Website
Founded
2003
ISIN
AU000000ZLD1
FIGI
BBG000K4GYF0
Zelira Therapeutics Ltd. is a bio-pharmaceutical company. The firm engages in the research and development of cannabinoid-based formulations for the treatment of a variety of medical conditions. It focuses on human clinical trial program and pre-clinical research program. The company was founded by Harry Karelis, Mara Gordon, Jason Peterson, and Stewart Washer on February 18, 2003 and is headquartered in Perth, Australia.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ZLD is 0.640 AUD — it has decreased by −1.54% in the past 24 hours. Watch ZELIRA THERAPEUTICS LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange ZELIRA THERAPEUTICS LIMITED stocks are traded under the ticker ZLD.
ZLD stock has fallen by −8.57% compared to the previous week, the month change is a −30.43% fall, over the last year ZELIRA THERAPEUTICS LIMITED has showed a −38.65% decrease.
ZLD stock is 3.13% volatile and has beta coefficient of 0.46. Track ZELIRA THERAPEUTICS LIMITED stock price on the chart and check out the list of the most volatile stocks — is ZELIRA THERAPEUTICS LIMITED there?
Today ZELIRA THERAPEUTICS LIMITED has the market capitalization of 7.49 M, it has decreased by −7.14% over the last week.
Yes, you can track ZELIRA THERAPEUTICS LIMITED financials in yearly and quarterly reports right on TradingView.
ZLD net income for the last half-year is −2.43 M AUD, while the previous report showed −34.13 M AUD of net income which accounts for 92.87% change. Track more ZELIRA THERAPEUTICS LIMITED financial stats to get the full picture.
No, ZLD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ZELIRA THERAPEUTICS LIMITED EBITDA is −5.69 M AUD, and current EBITDA margin is −6.00 K%. See more stats in ZELIRA THERAPEUTICS LIMITED financial statements.
Like other stocks, ZLD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ZELIRA THERAPEUTICS LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ZELIRA THERAPEUTICS LIMITED technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ZELIRA THERAPEUTICS LIMITED stock shows the sell signal. See more of ZELIRA THERAPEUTICS LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.